NOVO-B.CO

Novo Nordisk A/S [NOVO-B.CO] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

NOVO-B.CO Stock Summary

Top 10 Correlated ETFs

NOVO-B.CO


Top 10 Correlated Stocks

NOVO-B.CO


In the News

NOVO-B.CO Financial details

Company Rating
Strong Buy
Market Cap
3992.63B
Income
83.68B
Revenue
232.26B
Book val./share
23.8
Cash/share
6.75
Dividend
11.15
Dividend %
1.53%
Employees
63.37K
Optionable
No
Shortable
Yes
Earnings
02 May 2024
P/E
43.5
Forward P/E
31.77
PEG
36.89
P/S
15.15
P/B
35.23
P/C
130.56
P/FCF
41.77
Quick Ratio
0.63
Current Ratio
0.82
Debt / Equity
0.25
LT Debt / Equity
0.19
-
-
EPS (TTM)
27.4
EPS next Y
27.74
EPS next Q
5.35
EPS this Y
-23.83%
EPS next Y
1.25%
EPS next 5Y
43.61%
EPS last 5Y
17.92%
Revenue last 5Y
13.74%
Revenue Q/Q
12.14%
EPS Q/Q
-1.99%
-
-
-
-
SMA20
5.45%
SMA50
21.92%
SMA100
28.8%
Inst Own
-
Inst Trans
-
ROA
25%
ROE
87%
ROC
0.66%
Gross Margin
84%
Oper. Margin
39%
Profit Margin
35%
Payout
42%
Shs Outstand
4.5B
Shs Float
4.19B
-
-
-
-
Target Price
-
52W Range
504.4-932.0
52W High
-5.44%
52W Low
+74.86%
RSI
54
Rel Volume
0.9
Avg Volume
2.71M
Volume
2.45M
Perf Week
-2.29%
Perf Month
3.57%
Perf Quarter
35.56%
Perf Half Y
38.31%
-
-
-
-
Beta
0.175
-
-
Volatility
5.38%, 29.68%
Prev Close
0%
Price
881.3
Change
-1.53%

NOVO-B.CO Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-12-31

Metric History 2019-12-312020-12-312021-12-312022-12-31 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
25.6527.1330.5738.9451.67
Net income per share
8.19910.3712.2218.62
Operating cash flow per share
9.8311.111.9417.3624.23
Free cash flow per share
7.476.3810.3414.1115.58
Cash per share
3.252.733.85.196.73
Book value per share
12.1113.5315.3618.3723.71
Tangible book value per share
10.889.125.997.0610.27
Share holders equity per share
12.1113.5315.3618.3723.71
Interest debt per share
0.992.36.325.766.13
Market cap
919.7B998.34B1692.78B2131.42B3137.82B
Enterprise value
908.71B995.94B1708.7B2144.55B3150.43B
P/E ratio
23.6123.6935.4538.3937.5
Price to sales ratio
7.547.8612.0212.0513.51
POCF ratio
19.6619.2230.7827.0228.81
PFCF ratio
25.8733.4235.5533.2344.82
P/B Ratio
15.9715.7723.9325.5329.45
PTB ratio
15.9715.7723.9325.5329.45
EV to sales
7.457.8512.1412.1213.56
Enterprise value over EBITDA
15.7216.5425.2926.1427.89
EV to operating cash flow
19.4219.1731.0727.1928.93
EV to free cash flow
25.5633.3435.8933.4445
Earnings yield
0.040.040.030.030.03
Free cash flow yield
0.040.030.030.030.02
Debt to equity
0.080.160.380.310.25
Debt to assets
0.040.070.140.110.09
Net debt to EBITDA
-0.19-0.040.240.160.11
Current ratio
1.060.940.860.890.82
Interest coverage
238.56138.7823.93197.91189.25
Income quality
1.21.231.151.421.3
Dividend Yield
0.020.020.010.010.01
Payout ratio
0.50.480.450.460.38
Sales general and administrative to revenue
0.030.030.030.030.02
Research and developement to revenue
0.120.120.130.140.14
Intangibles to total assets
0.050.140.220.210.19
Capex to operating cash flow
-0.24-0.43-0.13-0.19-0.36
Capex to revenue
-0.09-0.17-0.05-0.08-0.17
Capex to depreciation
-1.98-3.84-1.23-2-4.13
Stock based compensation to revenue
00.010.010.010.01
Graham number
47.2252.3659.8671.0699.65
ROIC
0.640.550.470.530.59
Return on tangible assets
0.330.340.320.290.33
Graham Net
-4.59-7.57-13.32-17.36-23.44
Working capital
3.47B-4.46B-13.92B-12.75B-30.01B
Tangible asset value
51.76B42.67B27.58B32.07B46.16B
Net current asset value
-5.56B-15.79B-38.17B-49.58B-68.28B
Invested capital
0.080.160.380.310.25
Average receivables
28.02B30.67B39.49B52.15B66.38B
Average payables
6.56B6.04B7.29B12.23B20.6B
Average inventory
16.99B18.09B19.08B22B28.1B
Days sales outstanding
87.292.54121.32118.61118.27
Days payables outstanding
115.5399.69136.85199.99261.32
Days of inventory on hand
320.54323.22302.72312.91324.65
Receivables turnover
4.193.943.013.083.09
Payables turnover
3.163.662.671.831.4
Inventory turnover
1.141.131.211.171.12
ROE
0.680.670.680.670.79
Capex per share
-2.36-4.72-1.6-3.25-8.65

Quarterly Fundamentals Overview

Last date of statement is 2023-12-31 for Q4

Metric History 2022-12-312023-03-312023-06-302023-09-30 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
10.6311.8212.0613.0814.71
Net income per share
3.014.394.315.014.91
Operating cash flow per share
1.576.616.359.132.13
Free cash flow per share
0.215.544.786.76-1.54
Cash per share
5.216.158.0910.66.75
Book value per share
18.4617.720.0920.7223.8
Tangible book value per share
7.096.518.828.310.31
Share holders equity per share
18.4617.720.0920.7223.8
Interest debt per share
3.925.95.776.395.56
Market cap
2121.19B2450.22B2475.08B2890.47B3125.67B
Enterprise value
2134.32B2460.8B2479.21B2886.86B3138.29B
P/E ratio
39.0230.9231.8532.1535.58
Price to sales ratio
44.1145.9145.5849.2247.46
POCF ratio
298.7282.1886.6170.56327.26
PFCF ratio
2.29K97.96114.995.26-453.98
P/B Ratio
25.4130.6827.3631.0829.33
PTB ratio
25.4130.6827.3631.0829.33
EV to sales
44.3846.1145.6649.1547.65
Enterprise value over EBITDA
206.9389.2392.8188.13110.07
EV to operating cash flow
300.5782.5486.7670.47328.58
EV to free cash flow
2.3K98.38115.0995.14-455.82
Earnings yield
0.010.010.010.010.01
Free cash flow yield
00.010.010.010
Debt to equity
0.310.320.280.290.25
Debt to assets
0.110.10.090.090.09
Net debt to EBITDA
1.270.380.15-0.110.44
Current ratio
0.890.860.880.820.82
Interest coverage
-1.0322.2985.0112.41-12.74
Income quality
0.521.51.471.820.43
Dividend Yield
00.01000
Payout ratio
00.9300.60
Sales general and administrative to revenue
0.030.020.020.020.02
Research and developement to revenue
0.170.130.130.140.16
Intangibles to total assets
0.210.20.180.190.19
Capex to operating cash flow
-0.87-0.16-0.25-0.26-1.72
Capex to revenue
-0.13-0.09-0.13-0.18-0.25
Capex to depreciation
-3.03-2.79-3.23-4.21-5.49
Stock based compensation to revenue
0.030-0.08-0.060.36
Graham number
35.3341.8144.1748.3151.25
ROIC
0.060.190.160.180.15
Return on tangible assets
0.070.10.080.090.09
Graham Net
-17.44-19.08-19.32-21.89-23.53
Working capital
-12.75B-18.02B-19.07B-30.35B-30.01B
Tangible asset value
32.07B29.39B39.72B37.27B46.16B
Net current asset value
-49.58B-56.21B-52.73B-64.91B-68.28B
Invested capital
0.310.320.280.290.25
Average receivables
55.51B57.71B64.22B66.24B68.61B
Average payables
11.95B12.82B13.92B18.95B22.86B
Average inventory
23.81B25B26.82B28.78B30.67B
Days sales outstanding
107.6297.68116.8994.95102.84
Days payables outstanding
169.79110.55203.78186.3230.13
Days of inventory on hand
265.66281.76321273.66285.9
Receivables turnover
0.840.920.770.950.88
Payables turnover
0.530.810.440.480.39
Inventory turnover
0.340.320.280.330.31
ROE
0.160.250.210.240.21
Capex per share
-1.36-1.06-1.56-2.37-3.67

NOVO-B.CO Frequently Asked Questions

What is Novo Nordisk A/S stock symbol ?

Novo Nordisk A/S is a DK stock and trading under the symbol NOVO-B.CO

What is Novo Nordisk A/S stock quote today ?

Novo Nordisk A/S stock price is $881.3 today.

Is Novo Nordisk A/S stock public?

Yes, Novo Nordisk A/S is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks